Mohamed Sadek Abdel-Bakky (Mohamed S Abdel-Bakky, M S Abdel-Bakky)

Scopus Author ID Loop profile Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 10

Top Venues

BMC complementary medicine and therapies

Molecules (Basel, Switzerland)

Drug and chemical toxicology

Viruses

Al-Azhar University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Al-Azhar University Jul 15 2019

Egypt

Professor :: Pharmacology and Toxicology

Publications

Hayam S Ahmed, Enas I A Mohamed, Elham Amin, Abeer S Moawad, Mohamed Sadek Abdel-Bakky, Suliman A Almahmoud, Naglaa Afifi
Phytochemical investigation and anti-inflammatory potential of Atriplex leucoclada Boiss. BMC complementary medicine and therapies 23 (1) (2023)
Hayam S Ahmed, Enas I A Mohamed, Elham Amin, Abeer S Moawad, Mohamed Sadek Abdel-Bakky, Suliman A Almahmoud, Naglaa Afifi
Phytochemical investigation and anti-inflammatory potential of Atriplex leucoclada Boiss. BMC complementary medicine and therapies 23 (1) (2023)
Elham Amin, Mohamed Sadek Abdel-Bakky, Hamdoon A Mohammed, Marwa H A Hassan
Chemical Profiling and Molecular Docking Study of Agathophora alopecuroides . Life (Basel, Switzerland) 12 (11) (2022)
Elham Amin, Mohamed Sadek Abdel-Bakky, Mostafa Assem Darwish, Hamdoon A Mohammed, Sridevi Chigurupati, Kamal Ahmad Qureshi, Marwa H A Hassan
The Glycemic Control Potential of Some Amaranthaceae Plants, with Particular Reference to In Vivo Antidiabetic Potential of Agathophora alopecuroides . Molecules (Basel, Switzerland) 27 (3) (2022)
Mohamed Sadek Abdel-Bakky, Abdulmajeed Alqasoumi, Waleed M Altowayan, Elham Amin, Mostafa A Darwish
Resveratrol Inhibited ADAM10 Mediated CXCL16-Cleavage and T-Cells Recruitment to Pancreatic β-Cells in Type 1 Diabetes Mellitus in Mice. Pharmaceutics 14 (3) (2022)
Mohamed Sadek Abdel-Bakky, Elham Amin, Mohamed G Ewees, Nesreen I Mahmoud, Hamdoon A Mohammed, Waleed M Altowayan, Ahmed A H Abdellatif
Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 Vaccines. Viruses 14 (2) (2022)
Mohamed Abdelwahab Abdelgawad, Syed Nasir Abbas Bukhari, Arafa Musa, Mohammed Elmowafy, Mohammed H Elkomy, AbdEIAziz A Nayl, Ahmed H El-Ghorab, Ibrahim Hotan Alsohaimi, Mohamed Sadek Abdel-Bakky, Ibrahim O Althobaiti, Hamud A Altaleb, Hany A Omar, Ahmed H Abdelazeem, Mohamed A Zaki, Mohamed E Shaker, Heba A H Elshemy
New Sulfamethoxazole Derivatives as Selective Carbonic Anhydrase IX and XII Inhibitors: Design, Synthesis, Cytotoxic Activity and Molecular Modeling. Pharmaceuticals (Basel, Switzerland) 15 (9) (2022)
Mohamed Sadek Abdel-Bakky, G K Helal, E M El-Sayed, A H Alhowail, A M Mansour, K S Alharbi, Elham Amin, S Allam, S A Salama, A S Saad
Silencing of tissue factor by antisense deoxyoligonucleotide mitigates thioacetamide-induced liver injury. Naunyn-Schmiedeberg's archives of pharmacology 393 (10) (2020)
Mohammad K Ashfaq, Mohamed Sadek Abdel-Bakky, Mir Tahir Maqbool, Volodymyr Samoylenko, Aziz Abdur Rahman, Ilias Muhammad
Efficacy of Prosopilosidine from Prosopis glandulosa var. glandulosa against Cryptococcus neoformans Infection in a Murine Model. Molecules (Basel, Switzerland) 23 (7) (2018)
Mohamed G Ewees, Basim Anwar Shehata Messiha, Mohamed Sadek Abdel-Bakky, Asmaa M A Bayoumi, Ali A Abo-Saif
Tempol, a superoxide dismutase mimetic agent, reduces cisplatin-induced nephrotoxicity in rats. Drug and chemical toxicology 42 (6) (2018)

Mohamed Sadek Abdel-Bakky.css-eqlu8i{font-size:small;padding-left:4px;} (Mohamed S Abdel-Bakky, M S Abdel-Bakky)

Publication Activity (10 Years)

Top Topics

Top Venues

Mohamed Sadek Abdel-Bakky (Mohamed S Abdel-Bakky, M S Abdel-Bakky)